Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1033 | 1023 | 1094 | 1072 | 1148 | 1480 |
Fund Return | 3.3% | 2.33% | 9.43% | 2.35% | 2.81% | 4% |
Place in category | 891 | 792 | 966 | 359 | 903 | 271 |
% in Category | 32 | 29 | 35 | 18 | 44 | 24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bellevues Lux BB Adamant Medtech HB | 1.51B | 3.32 | -3.68 | 8.83 | ||
Adamant Medtech B EUR | 1.51B | 6.36 | 2.20 | 13.03 | ||
Adamant Medtech I EUR | 1.51B | 6.61 | 2.92 | 13.84 | ||
Adamant Medtech T EUR | 1.51B | 6.51 | 2.61 | 13.48 | ||
LU1477743386 | 425.38M | 3.29 | -1.65 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AllianzIncome Growth P H2EUR | 47.61B | 1.51 | -0.87 | 4.99 | ||
AllianzIncome Growth A H2EUR | 47.61B | 1.33 | -1.37 | 4.39 | ||
AllianzIncome Growth IT H2EUR | 47.61B | 1.58 | -0.73 | 5.09 | ||
AllianzIncome Growth CT H2EUR | 47.61B | 1.08 | -2.18 | 3.54 | ||
AllianzIncome Growth RT H2EUR | 47.61B | 1.49 | -0.90 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SWC (LU) BF Resp EmMa Opps DT | LU2108482071 | 3.38 | - | - | |
iShares Dev Rl Ett Idx (IE) Instl Acc $ | IE00B89M2V73 | 2.68 | - | - | |
iShares MSCI EM ESG Enhanced UCITS ETF USD Acc | IE00BHZPJ239 | 2.65 | 5.11 | -0.47% | |
Invesco Physical Gold ETC | IE00B579F325 | 2.20 | 226.15 | +0.28% | |
Twelve Cat Bond SI1 EUR Acc | IE00BKF1PS04 | 2.04 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review